Julie called into The Ramsey Show with a story many families recognize. Her family of five had been saving $100 a month for almost 12 years for a trip to Hawaii, while living on a $70,000 household income. They had saved $14,000, but now estimated the seven-night trip would cost…
Natural gas tumbled 5.6% on a bearish storage report and rising inventory, signaling oversupply concerns as summer demand season approaches.
A recently divorced 41-year-old called The Ramsey Show wondering whether she should cash out part of her 401(k) to eliminate $16,000 of student loans and $4,800 of orthodontics debt. Between child support, childcare expenses, and rebuilding her finances after divorce, she wanted…
A 28-year-old per diem nurse called The Ramsey Show looking for a second opinion after her husband proposed using part of her $143,000 Roth 403(b) to pay off the couple’s remaining $125,000 mortgage. While both wanted to become debt-free, she wasn’t convinced tapping retirement…
Opendoor rallied 11.6% despite mortgage rates climbing to 6.49%, suggesting buyers aren't deterred even as borrowing costs weigh on housing affordability.
SentinelOne shares jumped 8.6% in after-hours trading after rallying from the open. The cybersecurity leader is catching momentum as enterprise software demand accelerates.
Meta's AI infrastructure bet is paying off as Wall Street grows more confident in the company's digital advertising recovery and trillion-dollar compute expansion.
Arm, Marathon Digital, and SanDisk all jumped over 10% as semiconductor and AI infrastructure stocks dominated the close. Energy stocks fell, with Exxon Mobil sliding 2.6%.
Nurix missed earnings and revenue badly, but the $700 million Roche upfront arriving next quarter will vault cash to $1.14 billion and fund the leap into Phase 3 trials for lead BTK degrader bexobrutideg. The quarterly flop fades against a transformative collaboration that validates targeted protein degradation as the field's future.
WD-40 demolished earnings expectations with a 49% EPS beat as U.S. sales of its iconic Multi-Use Product surged on expanded distribution and e-commerce momentum, while management raised full-year guidance and authorized a $100 million share buyback.
Simulations Plus crushed EPS expectations by 29% and returned to GAAP profitability with a 7% revenue gain driven by 20% growth in services, positioning the biopharma software maker well ahead of its expected close with Altaris later this year.
S&P 500 climbs 0.75% as equities rally despite hawkish Fed signals pushing mortgage rates to six-month highs.